Mainstay Medical reportedly pulls in $25 million from a dual listing of its initial public offering in Paris and Dublin.
Mainstay Medical's (MSTY.PA) European initial public offering reeled in about $25 million (€18 million) and made the spinal implant maker the 1st medtech company to float an IPO in Paris and the 1st company to attempt a dual flotation in Paris and Dublin, the Irish Times reports.
News Well, Initial Public Offering (IPO), Neuromodulation/Neurostimulation, Pain Management, Spinal, Wall Street Beat
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1iNX83K
Cap comentari:
Publica un comentari a l'entrada